Mark Heipel

2.7k total citations
13 papers, 326 citations indexed

About

Mark Heipel is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Mark Heipel has authored 13 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Mark Heipel's work include CAR-T cell therapy research (6 papers), Lymphoma Diagnosis and Treatment (3 papers) and Biosimilars and Bioanalytical Methods (2 papers). Mark Heipel is often cited by papers focused on CAR-T cell therapy research (6 papers), Lymphoma Diagnosis and Treatment (3 papers) and Biosimilars and Bioanalytical Methods (2 papers). Mark Heipel collaborates with scholars based in United States, Denmark and Germany. Mark Heipel's co-authors include Joseph L. Kuijper, Cindy A. Sprecher, Rick D. Holly, Francis James Grant, Theodore E. Whitmore, Janet Kramer, Andrew Ching, Donald C. Foster, Andrew J. Fleetwood and Xiaoting Tang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Mark Heipel

13 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Heipel United States 7 136 125 73 50 50 13 326
Lucas van Eijk Netherlands 8 88 0.6× 127 1.0× 77 1.1× 24 0.5× 62 1.2× 16 328
Rénaté Bonier France 4 85 0.6× 131 1.0× 102 1.4× 18 0.4× 33 0.7× 5 320
MR Halie Netherlands 9 138 1.0× 141 1.1× 95 1.3× 55 1.1× 82 1.6× 17 448
Yulan Zhou China 4 137 1.0× 46 0.4× 83 1.1× 14 0.3× 51 1.0× 10 307
Pietro Delfino Italy 12 44 0.3× 71 0.6× 180 2.5× 57 1.1× 112 2.2× 17 378
Geneviève Marcoux Canada 8 77 0.6× 81 0.6× 199 2.7× 17 0.3× 25 0.5× 17 329
Edward Abadir Australia 8 48 0.4× 96 0.8× 51 0.7× 16 0.3× 53 1.1× 19 358
Huw B. Thomas United Kingdom 11 29 0.2× 173 1.4× 146 2.0× 23 0.5× 40 0.8× 20 378
Judith Bauer Germany 4 83 0.6× 216 1.7× 54 0.7× 20 0.4× 31 0.6× 4 345
Irene Fuhrmann Germany 7 107 0.8× 44 0.4× 64 0.9× 78 1.6× 23 0.5× 21 310

Countries citing papers authored by Mark Heipel

Since Specialization
Citations

This map shows the geographic impact of Mark Heipel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Heipel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Heipel more than expected).

Fields of papers citing papers by Mark Heipel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Heipel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Heipel. The network helps show where Mark Heipel may publish in the future.

Co-authorship network of co-authors of Mark Heipel

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Heipel. A scholar is included among the top collaborators of Mark Heipel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Heipel. Mark Heipel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
3.
Siddiqi, Tanya, Jeremy S. Abramson, Maria Lia Palomba, et al.. (2018). Correlation of patient characteristics and biomarkers with clinical outcomes of JCAR017 in R/R aggressive B-NHL (TRANSCEND NHL 001 study).. Journal of Clinical Oncology. 36(5_suppl). 122–122. 8 indexed citations
4.
Heipel, Mark, Jeffrey A. Smith, Mandana Karimi, et al.. (2017). Pharmacokinetic, Pharmacodynamic and Blood Analytes Associated with Clinical Response and Safety in Relapsed/Refractory Aggressive B-NHL Patients Treated with JCAR017. Blood. 130. 2835–2835. 1 indexed citations
5.
Kuijper, Joseph L., Siv A. Hjorth, Mark Heipel, et al.. (2015). Cutting Edge: Identification of Neutrophil PGLYRP1 as a Ligand for TREM-1. The Journal of Immunology. 194(4). 1417–1421. 122 indexed citations
6.
Schermuly, Ralph T., Mark Heipel, J. Bier, et al.. (2014). Arachidonic acid/cytochrome p450-derived mediators decrease hypoxic pulmonary vasoconstriction in isolated, ventilated and perfused mouse lungs. Pneumologie. 68(6). 1 indexed citations
7.
Kindsvogel, Wayne, S. Hughes, Mark Heipel, et al.. (2004). IL-21 enhances rituximab-mediated killing of B-lymphoma cell lines in vitro and in vivo. Journal of Clinical Oncology. 22(14_suppl). 2581–2581. 3 indexed citations
8.
Krejsa, Cecile M., Mark Heipel, Rick D. Holly, et al.. (2004). Mechanisms of IL-21 Enhancement of Rituximab Efficacy in a Lymphoma Xenograft Model.. Blood. 104(11). 1404–1404. 1 indexed citations
9.
Kindsvogel, Wayne, S. Hughes, Mark Heipel, et al.. (2004). IL-21 enhances rituximab-mediated killing of B-lymphoma cell lines in vitro and in vivo. Journal of Clinical Oncology. 22(14_suppl). 2581–2581. 5 indexed citations
10.
Whitmore, Theodore E., et al.. (1999). The assignment of the human insulin receptor-related receptor gene (INSRR) to chromosome 1q21→q23 by the use of radiation hybrid mapping. Cytogenetic and Genome Research. 87(1-2). 93–94. 2 indexed citations
11.
Foster, Donald C., Cindy A. Sprecher, Francis James Grant, et al.. (1994). Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization.. Proceedings of the National Academy of Sciences. 91(26). 13023–13027. 107 indexed citations
12.
Busby, Stephen, Eileen R. Mulvihill, A. Ashok Kumar, et al.. (1991). Expression of recombinant human plasminogen in mammalian cells is augmented by suppression of plasmin activity. Journal of Biological Chemistry. 266(23). 15286–15292. 48 indexed citations
13.
Busby, Stephen, et al.. (1988). 147 Expression of human plasminogen in baby hamster kidwey (BHK) cells. Fibrinolysis and Proteolysis. 2. 64–64. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucas van Eijk Breakdown of academic impact, for papers by Rénaté Bonier Breakdown of academic impact, for papers by MR Halie Breakdown of academic impact, for papers by Yulan Zhou Breakdown of academic impact, for papers by Pietro Delfino Breakdown of academic impact, for papers by Geneviève Marcoux Breakdown of academic impact, for papers by Edward Abadir Breakdown of academic impact, for papers by Huw B. Thomas Breakdown of academic impact, for papers by Judith Bauer Breakdown of academic impact, for papers by Irene Fuhrmann
Rankless by CCL
2026